Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
David Davis is hoping to push Brexit withdrawal talks towards discussions on a future trading relationship between the UK and EU.
A fine start to Sunday but rain moves in from the southwest later on.
A second police officer has died after he and a colleague were shot as they scuffled with a suspect in Florida.